ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19)
Condition: COVID-19 Vaccine Interventions: Biological: Gamma Variant RBD-based ARVAC-CG vaccine; Biological: Omicron Variant RBD-based ARVAC-CG vaccine; Biological: Bivalent RBD-based ARVAC-CG vaccine; Other: Placebo Sponsors: Mónica Edith Lombardo; Universidad Nacional de San Martín (UNSAM); National Council of Scientific and Technical Research, Argentina; Laboratorio Pablo Cassará S.R.L. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2023 Category: Research Source Type: clinical trials
Retinal Vascular Changes in Patients After Coronavirus Disease 2019 (COVID-19)
Condition: COVID-19 Interventions: Diagnostic Test: Central visual acuity; Diagnostic Test: Intraocular pressure measurement; Diagnostic Test: Slit lamp examination; Diagnostic Test: Retinal oximetry; Diagnostic Test: Optical coherence tomography and angiography Sponsors: University Hospital Olomouc; Palacky University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2023 Category: Research Source Type: clinical trials
